#cancer
Read more stories on Hashnode
Articles with this tag
Background: In the phase 3 HERO study, the oral GnRH receptor antagonist, relugolix, demonstrated suppression of testosterone to castrate levels in...
Methods:We enrolled an age- (30–49, 50–69, 70–89 years) and sex-stratified sample of 18 patients (PTs) who underwent a physical examination at 2 urban...
Background:A phase I/II clinical trial in advanced hepatocellular carcinoma (HCC) conducted by Yakult Honsha (NCT02400788) indicated the combination...
Age range 14–70 years old; ECOG performance status 0–2; Estimated survival time > 3 months Histological confirmed Peripheral T cell lymphoma None of...
Background: In ccRCC, HIF-2α is involved in the activation of genes such as VEGFA, cyclin D1, and CXCR4, which are associated with angiogenesis, tumor...
Background: Gilteritinib is an oral FMS-like tyrosine kinase 3 (FLT3) inhibitor that has demonstrated efficacy with favorable tolerability in patients...